Non-radiographic Axial Spondyloarthritis
Also known as: Non-radiographic Axial Spondyloarthritis (Nr-axSpA) / Non-Radiographical Axial Spondyloarthritis / Nonradiographic Axial Spondyloarthritis / Non-Radiographic, Axial Spondyloarthritis (SpA) / Non-radiographic axial spondyloarthritis (disorder) / Axial Spondyloarthritis / Axial spondyloarthritis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB08904 | Certolizumab pegol | A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. |
DB09029 | Secukinumab | An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB08904 | Certolizumab pegol | Tumor necrosis factor | target |
DB08904 | Certolizumab pegol | Alcohol dehydrogenase [NADP(+)] | enzyme |
DB09029 | Secukinumab | Interleukin-17A | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14845 | Filgotinib | 2 | Completed | 1 |
DB12917 | Bimekizumab | 3 | Completed | 1 |
DB08904 | Certolizumab pegol | 3 | Completed | 1 |
DB16756 | Ivarmacitinib | 3 | Recruiting | 1 |
DB09029 | Secukinumab | 3 | Active Not Recruiting | 1 |
DB09029 | Secukinumab | 4 | Recruiting | 1 |
DB00482 | Celecoxib | Not Available | Not Yet Recruiting | 1 |